中低位直肠癌新辅助治疗后全系膜切除术的难点与对策

Difficulties and strategies of total mesorectal excision for middle and low rectal cancer after neoadjuvant therapy

  • 摘要: 局部进展期直肠癌的新辅助放化疗(nCRT)可降低肿瘤局部复发率,使患者生存获益。但nCRT后组织水肿等因素导致组织间隙不清晰,淋巴结清扫和神经保护的难度增加。肿瘤临床完全缓解或接近临床完全缓解后肿瘤下切缘定位困难,以及nCRT后吻合口漏的风险增加等问题,为中低位直肠癌全系膜切除术带来困难和新挑战。笔者结合文献及自身临床经验,总结nCRT后全系膜切除术的难点及对策,以期为同道提供借鉴。

     

    Abstract: Patients with local advanced rectal cancer (LARC) can benefit from neoadju-vant chemoradiotherapy (nCRT) of reducing local recurrence rate and improving survival rate. However, tissue edema after nCRT may lead to unclear tissue spaces, making it challenging for lymph node dissection and nervous system protection. The difficulty in locating inferior margin of tumor after clinical complete remission or closing to clinical complete remission, as well as the increasing risk of anastomotic leakage after nCRT, pose difficulties and new challenges of total mesorectal excision for middle and low rectal cancer. Based on literatures and clinical experiences, the authors summarize the difficulties and strategies of total mesorectal excision after nCRT, in order to provide reference for colleagues.

     

/

返回文章
返回